GlaxoSmithKline Pakistan Limited (PSX:GLAXO)

GlaxoSmithKline Pakistan Revenue

GlaxoSmithKline Pakistan had revenue of 14.19B PKR in the quarter ending September 30, 2025, a decrease of -3.69%. This brings the company's revenue in the last twelve months to 62.07B, up 10.39% year-over-year. In the year 2024, GlaxoSmithKline Pakistan had annual revenue of 61.19B with 23.21% growth.

• Revenue (ttm): 62.07B
• Revenue Growth: +10.39%
• P/S Ratio: 2.03
• Revenue / Employee: 36.51M
• Employees: 1,700
• Market Cap: 125.87B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	61.19B	11.53B	23.21%
Dec 31, 2023	49.66B	7.82B	18.69%
Dec 31, 2022	41.84B	5.18B	14.13%
Dec 31, 2021	36.66B	1.57B	4.48%
Dec 31, 2020	35.09B	-1.49B	-4.08%